Fusion Pharmaceuticals is redefining precision oncology with next-generation radioconjugates delivering alpha-emitting payloads directly to tumors.
Base: $82,377.60 to $108,120.60; Bonus/Equity: Annual Variable Pay Bonus and Long-Term Incentive Program eligibility; Benefits: Flex Benefits, Retirement Savings, 4 weeks vacation, annual Personal Days
Must-have
Nice-to-have
Not specified